Authors:
Frenzel, S
Apel, TW
Heidemann, PH
Zerres, K
Neumann, HPH
Dorr, HG
Citation: S. Frenzel et al., Phaeochromocytoma associated with a de novo VHL mutation as form fruste ofvon Hippel-Lindau disease, EUR J PED, 160(7), 2001, pp. 421-424
Authors:
Glasker, S
Bender, BU
Apel, TW
van Velthoven, V
Mulligan, LM
Zentner, J
Neumann, NPH
Citation: S. Glasker et al., Reconsideration of biallelic inactivation of the VHL tumour suppressor gene in hemangioblastomas of the central nervous system, J NE NE PSY, 70(5), 2001, pp. 644-648
Authors:
Januszewicz, A
Neumann, HPH
Lon, I
Szmigielski, C
Symonides, B
Kabat, M
Apel, TW
Wocial, B
Lapinski, M
Januszewicz, W
Citation: A. Januszewicz et al., Incidence and clinical relevance of RET proto-oncogene germline mutations in pheochromocytoma patients, J HYPERTENS, 18(8), 2000, pp. 1019-1023
Authors:
Glasker, S
Bender, BU
Apel, TW
Natt, E
van Velthoven, V
Scheremet, R
Zentner, J
Neumann, HPH
Citation: S. Glasker et al., The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system, J NE NE PSY, 67(6), 1999, pp. 758-762